Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Cancer. 2016 Jun 10;122(19):3051–3058. doi: 10.1002/cncr.30138

Figure 1.

Figure 1

Early lesional response with respect to timing of immunotherapy for (a) the entire cohort as well as (b) a subset of patients with both concurrent and non-current SRS treatments. Error bars denote the interquartile range of volume change at each time point.